Pain at the end of life: Difference between revisions

From IDWiki
(Imported from text file)
 
No edit summary
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
  +
== Management ==
Including use of opioids and other medications
 
   
== General Approach ==
+
===General approach===
   
* Assess the symptom
+
*Assess the symptom
* Reverse what you can
+
*Reverse what you can
* Treat what remains
+
*Treat what remains
* Monitor frequently
+
*Monitor frequently
   
== Opioids ==
+
===Opioids===
   
* Codeine (~10% lack enzyme to convert to morphine)
+
*[[Codeine]]: ~10% lack enzyme to convert to morphine
* Morphine (has toxic products that cause delirium that are renally cleared)
+
*[[Morphine]]: has toxic products that cause delirium that are renally cleared
  +
*See [[opioids]] for more information, including an equianalgesia chart
* Oxycodone
 
** Percocet (5mg oxycodone, 325mg acetaminophen)
 
* Hydromorphone
 
* Fentanyl
 
* Methadone
 
   
== Starting Dose ==
+
====Starting Dose====
   
* If naive (<7-10 days), low is best
+
*If naive (<7-10 days), low is best
** Morphine 2.5-5.0mg po q4h
+
**[[Morphine]] 2.5-5.0mg po q4h
** Hydromorphone 0.5-1.0mg po q4h
+
**[[Hydromorphone]] 0.5-1.0mg po q4h
   
== Breakthrough ==
+
====Breakthrough====
   
* 10% of TDD (i.e. 1/2 of the q4h dose) q1h prn
+
*10% of TDD (i.e. 1/2 of the q4h dose) q1h prn
* Peak effectiveness reached around 1h after oral dose
+
*Peak effectiveness reached around 1h after oral dose
   
  +
====Titration====
== Opioid Equivalence Chart ==
 
   
 
*When stable, add breakthrough doses to standing
{|
 
 
*Don't add it if used for incident pain (e.g. associated with specific activities)
! Opioid
 
!align="center"| PO dose (mg)
 
!align="center"| SC/IV dose (mg)
 
|-
 
| Codeine
 
|align="center"| 100
 
|align="center"| —
 
|-
 
| Morphine
 
|align="center"| 10
 
|align="center"| 5
 
|-
 
| Oxycodone
 
|align="center"| 5
 
|align="center"| —
 
|-
 
| Hydromorphone
 
|align="center"| 2
 
|align="center"| 1
 
|-
 
| Fentanyl
 
|align="center"|
 
|align="center"|
 
|}
 
   
== Titration ==
+
==== Rotation ====
   
  +
* Opioid rotation may decrease some side effects, including hyperanalgesia and delirium
* When stable, add breakthrough doses to standing
 
  +
* Use the [[Opioids|equianalgesia chart]] to convert to and from oral morphine equivalents
* Don't add it if used for incident pain (e.g. associated with specific activities)
 
  +
* In general, decrease the total daily dose by about 20% when rotating to a new opioid
   
  +
====Management of side effects====
== Side Effects ==
 
   
* Constipation
+
*[[Constipation]]
* Drowsiness
+
*Drowsiness:
** Decrease dose if can't keep eyes open or can't complete a conversation
+
**Decrease dose if can't keep eyes open or can't complete a conversation
* Nausea
+
*[[Nausea]]
** Add Gravol unless already on an antiemetic
+
**Add [[dimenhydrinate]] unless already on an antiemetic
** Should settle within a week
+
**Should settle within a week
* Delirium
+
*[[Delirium]]
** Opioid rotation
+
**Opioid rotation
** Haloperidol (standing, if necessary)
+
**[[Haloperidol]] (standing, if necessary)
   
 
[[Category:Palliative care]]
 
[[Category:Palliative care]]

Latest revision as of 11:35, 29 July 2020

Management

General approach

  • Assess the symptom
  • Reverse what you can
  • Treat what remains
  • Monitor frequently

Opioids

  • Codeine: ~10% lack enzyme to convert to morphine
  • Morphine: has toxic products that cause delirium that are renally cleared
  • See opioids for more information, including an equianalgesia chart

Starting Dose

Breakthrough

  • 10% of TDD (i.e. 1/2 of the q4h dose) q1h prn
  • Peak effectiveness reached around 1h after oral dose

Titration

  • When stable, add breakthrough doses to standing
  • Don't add it if used for incident pain (e.g. associated with specific activities)

Rotation

  • Opioid rotation may decrease some side effects, including hyperanalgesia and delirium
  • Use the equianalgesia chart to convert to and from oral morphine equivalents
  • In general, decrease the total daily dose by about 20% when rotating to a new opioid

Management of side effects